Reskovic Luksic, Vlatka; Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Zagreb, Croatia.
Separovic Hanzevacki, Jadranka; Department of Cardiovascular Diseases, University of Zagreb School of Medicine and University Hospital Centre Zagreb, Zagreb, Croatia.
Trung, Mai-Linh Nguyen; Department of Cardiology, CHU Sart Tilman, University of Liège Hospital, GIGA Cardiovascular Sciences, Liège, Belgium.
PETITJEAN, Hélène ; Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
Lancellotti, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
Language :
English
Title :
The burden and challenges of managing aortic stenosis.
Lancellotti P, Rosenhek R, Pibarot P, et al.ESC working group on valvular heart disease position paper—heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34(21):1597–1606. doi: 10.1093/eurheartj/ehs443.
Lancellotti P, Petitjean H, Postolache A, et al.Focus on valvular heart disease. Acta Cardiol. 2022;77(10):861–863. doi: 10.1080/00015385.2022.2159193.
Santangelo G, Bursi F, Faggiano A, et al.The global burden of valvular heart disease: from clinical epidemiology to management. JCM. 2023;12(6):2178. doi: 10.3390/jcm12062178.
Pibarot P, Lancellotti P., Knowledge and application of European Society of Cardiology (ESC) guidelines in the management of mitral regurgitation: this is not bad but we can do much better. Eur Heart J. 2018;39(15):1304–1307. doi: 10.1093/eurheartj/ehy158.
Iung B, Delgado V, Lazure P, et al.Educational needs and application of guidelines in the management of patients with mitral regurgitation. A european mixed-methods study. Eur Heart J. 2018;39(15):1295–1303. doi: 10.1093/eurheartj/ehx763.
Coisne A, Lancellotti P, Habib G, et al.ACC/AHA and ESC/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison. J Am Coll Cardiol. 2023;82(8):721–734. doi: 10.1016/j.jacc.2023.05.061.
Proença T, Sousa C, Alves Pinto R, et al.Dissection of anterior mitral valve leaflet masking severe mitral regurgitation - an unusual case of infective endocarditis. Acta Cardiol. 2022;77(5):456–458. doi: 10.1080/00015385.2021.1950370.
Malergue MC, Ohanessian A, Zannis K, et al.Dexfenfluramin: a forgotten cause of aortic stenosis. Acta Cardiol. 2020;75(3):269–270. doi: 10.1080/00015385.2019.1580857.
Çakır Ç, Ceylan Y, Karagöz A, et al.Percutaneous mitral commissurotomy in women with asymptomatic severe mitral stenosis before pregnancy. Acta Cardiol. 2021;76(7):754–759. doi: 10.1080/00015385.2020.1783778.
Ennezat PV, Arnaud-Crozat E, Guerbaai RA, et al.Fenfluramine induced mitral stenosis complicated by massive left atrial thrombosis. Acta Cardiol. 2021;76(2):216–217. doi: 10.1080/00015385.2020.1722349.
Al Hage E, Scarfo P, Lochy S, et al.Transcatheter edge-to-edge repair of a torrential tricuspid regurgitation with a single 4th generation TriClipTM system. Acta Cardiol. 2022;77(10):974–975. doi: 10.1080/00015385.2022.2054497.
Bakelants E, Belmans A, Verbrugghe P, et al.Clinical outcomes of heart-team-guided treatment decisions in high-risk patients with aortic valve stenosis in a health-economic context with limited resources for transcatheter valve therapies. Acta Cardiol. 2019;74(6):489–498. doi: 10.1080/00015385.2018.1522461.
Rietz M, Aminian A, Droogmans S, et al.Transcatheter edge-to-edge mitral valve repair as a bridge to optimal guideline-directed medical therapy. Acta Cardiol. 2022;77(7):655–657. doi: 10.1080/00015385.2021.1917795.
Kocyigit D, Tokgozoglu L, Gurses KM, et al.Association of dietary and gut microbiota-related metabolites with calcific aortic stenosis. Acta Cardiol. 2021;76(5):544–552. doi: 10.1080/00015385.2020.1853968.
Cheng SQ, Liu NF, Fang LJ, et al.Factors predicting the occurrence of aortic valve calcification in patients with coronary artery calcification in China. Acta Cardiol. 2022;77(10):910–917. doi: 10.1080/00015385.2022.2072053.
Avci Y, Demir AR, Duran M, et al.The prognostic value of C-reactive protein to albumin ratio in patients undergoing transcatheter aortic valve implantation. Acta Cardiol. 2022;77(10):930–936. doi: 10.1080/00015385.2022.2119658.
Kammoun I, Sghaier A, Bennour E, et al.Current and new imaging techniques in risk stratification of asymptomatic severe aortic stenosis. Acta Cardiol. 2022;77(4):288–296. doi: 10.1080/00015385.2021.1939513.
Lancellotti P, Magne J, Dulgheru R, et al.Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol. 2018;3(11):1060–1068. doi: 10.1001/jamacardio.2018.3152.
Coffey S, Roberts-Thomson R, Brown A, et al.Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853–864. doi: 10.1038/s41569-021-00570-z.
Lancellotti P., Grading aortic stenosis severity when the flow modifies the gradient-valve area correlation. Cardiovasc Diagn Ther. 2012;2(1):6–9. doi: 10.3978/j.issn.2223-3652.2012.02.03.
Silva I, Salaun E, Côté N, et al.Confirmation of aortic stenosis severity in case of discordance between aortic valve area and gradient. JACC Case Rep. 2022;4(3):170–177. doi: 10.1016/j.jaccas.2021.11.009.
Pibarot P, Lancellotti P, Narula J., Concomitant cardiac amyloidosis in severe aortic stenosis: the trojan horse?J Am Coll Cardiol. 2021;77(2):140–143. doi: 10.1016/j.jacc.2020.11.007.
Lancellotti P, Pellikka PA, Budts W, et al.The clinical use of stress echocardiography in non-ischaemic heart disease. Eur Heart J Cardiovasc Imaging. 2016;17(11):1191–1229. doi: 10.1093/ehjci/jew190.
Dulgheru R, Pibarot P, Sengupta PP, et al.Multimodality imaging strategies for the assessment of aortic stenosis: viewpoint of the heart valve clinic international database (HAVEC) group. Circ Cardiovasc Imaging. 2016;9(2):e004352. doi: 10.1161/CIRCIMAGING.115.004352.
Oh JK, Ito S., Severity of aortic stenosis: a moving target. J Am Coll Cardiol. 2022;80(7):677–680. doi: 10.1016/j.jacc.2022.05.037.
Stassen J, Ewe SH, Singh GK, et al.Prevalence and prognostic implications of discordant grading and flow-gradient patterns in moderate aortic stenosis. J Am Coll Cardiol. 2022;80(7):666–676. doi: 10.1016/j.jacc.2022.05.036.
Stassen J, Ewe SH, Pio SM, et al.Managing patients with moderate aortic stenosis. JACC Cardiovasc Imaging. 2023;16(6):837–855. doi: 10.1016/j.jcmg.2022.12.013.
Park DY, An S, Kassab K, et al.Chronological comparison of TAVI and SAVR stratified to surgical risk: a systematic review, meta-analysis, and meta-regression. Acta Cardiol. 2023;78(7):778–789. doi: 10.1080/00015385.2023.2218025.
Vandenbossche JL, Briki R, de Hemptinne Q, et al.Trends and outcomes in transcatheter aortic valve implantation: evolution of a revolution. Acta Cardiol. 2022;77(10):984–985. doi: 10.1080/00015385.2022.2129181.
Angellotti D, Manzo R, Castiello DS, et al.Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation. Acta Cardiol. 2022;77(10):937–942. doi: 10.1080/00015385.2022.2119660.
Bezzeccheri A, Vermeersch P, Verheye S, et al.Trends and outcomes in transcatheter aortic valve implantation in Belgium: a 13-year single Centre experience. Acta Cardiol. 2022;77(10):960–969. doi: 10.1080/00015385.2022.2130444.
Galli E, Donal E., TAVI in the COVID-19 pandemic. How to balance waiting list concerns and straightforward management. Acta Cardiol. 2023;78(7):852–853. doi: 10.1080/00015385.2022.2148893.
De Paepe J, Lamberigts M, Meuris B, et al.Transcatheter aortic valve implantation versus sutureless aortic valve replacement: a single-centre cost analysis. Acta Cardiol. 2023;26:1–11. doi: 10.1080/00015385.2023.2268441.
Koutsoukis A, Nahory L, Deguillard C, et al.Timing of aortic valve replacement in high-gradient severe aortic stenosis: impact of left ventricular ejection fraction. Acta Cardiol. 2021;76(5):517–524. doi: 10.1080/00015385.2020.1851495.
Şener YZ, Okşul M, Pehlivan M., Effects of anaemia on TAVR outcomes. Acta Cardiol. 2021;76(1):104–104. doi: 10.1080/00015385.2019.1690263.
Van de Velde-Van De Ginste S, Perkisas S, Vermeersch P, et al.Physical components of frailty in predicting mortality after transcatheter aortic valve implantation (TAVI). Acta Cardiol. 2021;76(7):681–688. doi: 10.1080/00015385.2020.1769346.
Kucukosmanoglu M, Kilic S, Urgun OD, et al.Impact of objective nutritional indexes on 1-year mortality after transcatheter aortic valve implantation: a prospective observational cohort study. Acta Cardiol. 2021;76(4):402–409. doi: 10.1080/00015385.2020.1747177.
Strachinaru M, Ren B, van Dalen BM, et al.Determinants of changes in pulmonary artery pressure in patients with severe aortic stenosis treated by transcatheter aortic valve implantation. Acta Cardiol. 2021;76(2):185–193. doi: 10.1080/00015385.2019.1708599.
Deveci OS, Okutucu S, Fatihoglu SG, et al.Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art. Acta Cardiol. 2022;77(3):196–203. doi: 10.1080/00015385.2021.1909276.
von Kemp MJ, Floré V, Lau CW, et al.Impact of routine use of a cerebral protection device on the TAVR procedure and its short-term outcomes: a single-centre experience. Acta Cardiol. 2022;77(10):922–929. doi: 10.1080/00015385.2022.2111128.
Okutucu S, Niazi AK, Oliveira D, et al.A systematic review on durability and structural valve deterioration in TAVR and surgical AVR. Acta Cardiol. 2021;76(9):921–932. doi: 10.1080/00015385.2020.1858250.
Wang B, Mei Z, Ge X, et al.Comparison of outcomes of self-expanding versus balloon-expandable valves for transcatheter aortic valve replacement: a meta-analysis of randomized and propensity-matched studies. BMC Cardiovasc Disord. 2023;23(1):382. doi: 10.1186/s12872-023-03397-3.
Aladham A, Gada H, Wang Y, et al.Incidence of permanent pacemaker implantation using the cusp overlap technique: a large single-center analysis. JACC Cardiovasc Interv. 2022;15(9):1006–1008. doi: 10.1016/j.jcin.2022.03.005.
Carroll JD, Mack MJ, Vemulapalli S, et al.STS-ACC TVT registry of transcatheter aortic valve replacement. Ann Thorac Surg. 2021;111(2):701–722. doi: 10.1016/j.athoracsur.2020.09.002.
Dubois C, Adriaenssens T, Annemans L, et al.Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium. Acta Cardiol. 2023:1–12. doi: 10.1080/00015385.2023.2282283.
Lancellotti P, Fattouch K, Modine T., Is transcatheter aortic valve implantation for aortic stenosis cost-effective? Acta Cardiol. 2023;14:1–3. doi: 10.1080/00015385.2023.2281110.
